Accelerate Decisions with Certara IQ™: Scalable, AI-Driven QSP for Drug Development
Discover how Certara's AI-powered QSP modeling software, Certara IQ is overcoming challenges in drug development…
CertaraFebruary 17, 2026
Certara IQ™ Global Roadshow
Certara IQ™ is going on the road. From APAC to Europe to North America, our…
CertaraFebruary 12, 2026
Anti-PD-(L)1 Antibodies: Insights From QSP-Based Meta-Analysis
Anti-PD-1 and anti-PD-L1 antibodies have transformed cancer immunotherapy, yet clinical meta-analyses suggest differences in efficacy…
CertaraFebruary 11, 2026
How Quantitative Systems Pharmacology Addresses Key Challenges in Alzheimer’s Drug Development
Quantitative Systems Pharmacology (QSP) helps address key challenges in Alzheimer’s disease drug development, including tau…
CertaraFebruary 2, 2026
First-in-human dosing model for MDX2004, a novel trispecific CD3xCD28/4-1BB antibody-fusion protein for advanced malignancies
Learn how QSP modeling enabled safe, data-driven FIH dose prediction for the trispecific T-cell activator…
CertaraDecember 16, 2025
